PFM Health Sciences’s Apple AAPL Stock Holding History

PFM Health Sciences’s Portfolio AAPL Stock Details AAPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,264,400	Closed	-$303K	–	75
2015 Q2	$303K	Buy	+2,264,400	New	+$72.4M	0.01%	87

Other funds holding AAPL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PFM Health Sciences's AAPL Position: Q4 2018 in Review

PFM Health Sciences sold out of Apple (AAPL) in Q4 2018, closing a stake of 1,126,512 shares — an estimated $63.6M sold.

PFM Health Sciences first reported a position in AAPL in Q3 2013 and held it in 10 quarters. The position peaked at $118M in Q1 2016. 3,039 funds tracked by Wall St. Rank hold AAPL as of Q4 2018.

PFM Health Sciences reported no remaining Apple position as of Q4 2018 after selling out during the quarter.
PFM Health Sciences sold 1,126,512 Apple shares in Q4 2018, an estimated $63.6M.
PFM Health Sciences first reported a position in Apple in Q3 2013 and held it in 10 quarters.
PFM Health Sciences's Apple position peaked at $118M in Q1 2016.
3,039 funds tracked by Wall St. Rank held Apple as of Q4 2018.

Based on PFM Health Sciences's 13F filing for Q4 2018, filed 14 Feb 2019.